Neuropeptide Y: The Story, the Players, the Outcomes-Reference-Cited by-同舟云学术

Neuropeptide Y: The Story, the Players, the Outcomes

Published:2012 Issue: Volume: Page:227-255
ISSN:
Container-title:Nerve-Driven Immunity
language:
Short-container-title:

Author:

Dimitrijević Mirjana,Stanojević Stanislava

Publisher

Springer Vienna

Link

http://link.springer.com/content/pdf/10.1007/978-3-7091-0888-8_8.pdf

Reference147 articles.

1. Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A, Ushijima T (2008) Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology 74:50–60

2. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63:1684–1695

3. Ahmed AA, Mutt V, Nordlind K (1999) Modulating effects of sensory and autonomic neuropeptides on murine splenocyte proliferation and cytokine secretion induced by Leishmania major. Immunopharmacol Immunotoxicol 21:507–526

4. Ahmed AA, Wahbi AH, Nordlin K (2001) Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immunotoxicol 23:397–409

5. Amlal H, Faroqui S, Balasubramaniam A, Sheriff S (2006) Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer Res 66:3706–3714

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells;Neuropeptides;2021-10

2. Neuroendocrine and immune disequilibrium as a probable link between metabolic syndrome and carcinogenesis;Medical Hypotheses;2018-09

3. Metabolic syndrome – From the neurotrophic hypothesis to a theory;Medical Hypotheses;2013-10